SCIENCE
Ozempic and Wegovy linked to nearly 40% fewer asthma attacks
ScienceDailyWednesday, September 9, 2026 at 1:06 PM
RedScroll Brief

Semaglutide, the drug found in Ozempic and Wegovy, was linked to nearly 40% fewer asthma attacks in a large real-world study. It was also associated with about 20% fewer COPD flare-ups.
RedScroll Signal
- Impact
- High
- Category
- Science
- Market relevance
- None
- Why it matters
- Scientific signal separates durable discovery from noise — and often foreshadows policy and product. Semaglutide, the drug found in Ozempic and Wegovy, was linked to nearly 40% fewer asthma attacks in a large real-world study. It was also associated with about 20% fewer COPD flare-ups.
Desk copy
RedScroll Briefing
Extractive editorial brief — not a reprint of the original
What happened
Semaglutide, the drug found in Ozempic and Wegovy, was linked to nearly 40% fewer asthma attacks in a large real-world study. It was also associated with about 20% fewer COPD flare-ups.
Why it matters
Scientific signal separates durable discovery from noise — and often foreshadows policy and product.
Background
ScienceDaily reported on this under science. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.
Timeline
ScienceDaily published: Ozempic and Wegovy linked to nearly 40% fewer asthma attacks
Story is in today’s RedScroll edition. Follow the original source for updates.
More on
Related stories
- Ozempic and Wegovy may have an unexpected mental health benefit
ScienceDailySCIENCE
- Bacteria recruited to treat cancer
NatureSCIENCE
- The Einstein test: what happens when AI tries to rediscover relativity?
NatureSCIENCE
- Highly efficient base editing at PCSK9 and normal human embryo development
NatureSCIENCE
- How AI is changing PhD programmes: join our free webinar
NatureSCIENCE
- Phone tutoring boosts math scores when schools are forced to close
NatureSCIENCE
Source
ScienceDaily
Original reporting by ScienceDaily. RedScroll provides an extractive briefing only.